Table 3. Factors associated with prevalent long-term opioid use in 1997 and 2005 in Kaiser Permanente.
1997 |
2005 |
|||||
---|---|---|---|---|---|---|
PR | (95% CI) | P | PR | (95% CI) | P | |
Age | ||||||
≥50 years | 0.9 | (0.6, 1.4) | 0.76 | 1.3 | (0.9, 2.1) | 0.20 |
40-49 years | 0.8 | (0.6, 1.2) | 0.31 | 1.6 | (1.1, 2.4) | 0.025 |
18-39 years (reference) | 1 | 1 | ||||
Female | 2.0 | (1.3, 3.0) | 0.001 | 1.8 | (1.3, 2.5) | <0.001 |
White Race/ethnicity | 1.4 | (1.0, 2.0) | 0.069 | 1.3 | (1.0, 1.7) | 0.083 |
Years known HIV+ | ||||||
≥10 | 1.4 | (0.9, 2.2) | 0.111 | 1.4 | (1.0, 2.1) | 0.053 |
5-9.9 | 1.1 | (0.8, 1.5) | 0.75 | 1.1 | (0.7, 1.7) | 0.66 |
<5 (reference) | 1 | 1 | ||||
History of injection drug use | 2.1 | (1.5, 3.2) | <0.001 | 1.8 | (1.3, 2.6) | 0.001 |
Prior use of antiretrovirals | 1.5 | (0.9, 2.5) | 0.085 | 1.1 | (0.7, 1.8) | 0.62 |
CD4+ T-cell counts (per 100) | 1.0 | (0.9, 1.1) | 0.70 | 1.0 | (0.9, 1.0) | 0.138 |
HIV virus levels (per log) | 1.2 | (1.0, 1.4) | 0.027 | 1.1 | (0.9, 1.3) | 0.36 |
Prior AIDS diagnosis | 2.0 | (1.2, 3.1) | 0.004 | 1.2 | (0.9, 1.6) | 0.250 |
Charlson comorbidity index2,3 | ||||||
≥2 | 1.9 | (1.4, 2.8) | <0.001 | |||
1 | 1.6 | (1.2, 2.1) | 0.003 | |||
0 (reference) | 1.0 | (1.0, 1.0) | . | |||
Prior depression diagnosis3 | 1.3 | (1.0, 1.7) | 0.058 | |||
Prior substance use disorders3 | 1.8 | (1.3, 2.5) | <0.001 |
PR, prevalence ratio; CI, confidence interval
Adjusted prevalence ratios obtained from modified Poisson regression models using Proc Genmod in SAS. Models are adjusted for all variables in table.
Modified Charlson comorbidity scores based on inpatient or outpatient diagnoses, excluding HIV/AIDS.
Prior Charlson comorbidity scores, depression diagnoses, and substance use disorders were assessed in two years prior to start of calendar year and not available for 1997.